Terms: = Pancreatic cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
108 results:
1. Undifferentiated Carcinoma with Osteoclast-like Giant Cells of the Pancreas: Molecular Genetic Analysis of 13 Cases.
Hrudka J; Kalinová M; Ciprová V; Moravcová J; Dvořák R; Matěj R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542259
[TBL] [Abstract] [Full Text] [Related]
2. Causes of death and nomogram for patients with oncologic hepato-biliary-pancreatic disorders: A large-cohort study.
Xu J; Huang S; Yan Q; Jiang J; Hu N; Zhang W; Shi L; Deng M; Tang X; Liao J
Medicine (Baltimore); 2024 Feb; 103(8):e37187. PubMed ID: 38394524
[TBL] [Abstract] [Full Text] [Related]
3. [Tolerability and Outcome of Neoadjuvant GS Therapy for Resectable pancreatic cancer].
Yamashita M; Shimizu J; Sato Y; Noma T; Hagihara K; Yanagimoto Y; Suzuki Y; Ikenaga M; Kawase T; Imamura H; Akagi K; Iwasawa S; Tomita N
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1411-1413. PubMed ID: 38303291
[TBL] [Abstract] [Full Text] [Related]
4. Relationship Between Immunophenotypes, Genetic Profiles, and Clinicopathologic Characteristics in Small Bowel Adenocarcinoma.
Hoshimoto A; Tatsuguchi A; Yamada T; Kuriyama S; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Gudis K; Mitsui K; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K
Am J Surg Pathol; 2024 Feb; 48(2):127-139. PubMed ID: 38062562
[TBL] [Abstract] [Full Text] [Related]
5. Development of a nomogram to predict survival in advanced biliary tract cancer.
Imaoka H; Ikeda M; Nomura S; Morizane C; Okusaka T; Ozaka M; Shimizu S; Yamazaki K; Okano N; Sugimori K; Shirakawa H; Mizuno N; Satoi S; Yamaguchi H; Sugimoto R; Gotoh K; Sano K; Asagi A; Nakamura K; Ueno M
Sci Rep; 2023 Dec; 13(1):21548. PubMed ID: 38057434
[TBL] [Abstract] [Full Text] [Related]
6. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Impact of Minimal Pelvic Fluid in Locally Advanced pancreatic cancer: A Multicenter Retrospective Study.
Lee J; Park JS; Jeong S; Lee DH; Lim JH; Cho SG; Kwon CI; Hyun JJ; Choe JW; Cho JH; Jang SI
Turk J Gastroenterol; 2023 Dec; 34(12):1249-1256. PubMed ID: 37860834
[TBL] [Abstract] [Full Text] [Related]
8.
Tobi M; Weinstein D; Kim M; Hatfield J; Sochacki P; Levi E; An T; Hamre M; Tolia V; Fligiel S; Marepally R; Hallman J; Bapat B; Yuan M; McVicker B; Gallinger S
Curr Oncol; 2023 Aug; 30(9):7950-7963. PubMed ID: 37754493
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes.
Li Q; Liu H; Jin Y; Yu Y; Wang Y; Wu D; Guo Y; Xi L; Ye D; Pan Y; Zhang X; Li J
Comput Biol Med; 2023 Oct; 165():107370. PubMed ID: 37643511
[TBL] [Abstract] [Full Text] [Related]
10. An age-group analysis on the efficacy of chemotherapy in older adult patients with metastatic biliary tract cancer: a Japanese cancer registry cohort study.
Hirao T; Ikezawa K; Morishima T; Daiku K; Seiki Y; Watsuji K; Kawamoto Y; Higashi S; Urabe M; Kai Y; Takada R; Yamai T; Mukai K; Nakabori T; Uehara H; Miyashiro I; Ohkawa K
BMC Gastroenterol; 2023 Aug; 23(1):263. PubMed ID: 37528334
[TBL] [Abstract] [Full Text] [Related]
11. Clinical Efficacy of Neoadjuvant Chemotherapy with Gemcitabine plus S-1 for Resectable pancreatic Ductal Adenocarcinoma Compared with Upfront Surgery.
Kitano Y; Inoue Y; Takeda T; Oba A; Ono Y; Sato T; Ito H; Ozaka M; Sasaki T; Sasahira N; Baba H; Takahashi Y
Ann Surg Oncol; 2023 Aug; 30(8):5093-5102. PubMed ID: 37140750
[TBL] [Abstract] [Full Text] [Related]
12. Epidemiological trends for functional pancreatic neuroendocrine tumors: A study combining multiple imputation with age adjustment.
Luo S; Wang J; Wu L; Wang C; Yang J; Li M; Zhang L; Ge J; Sun C; Li E; Lei J; Liao Y; Zhou F; Liao W
Front Endocrinol (Lausanne); 2023; 14():1123642. PubMed ID: 37113484
[TBL] [Abstract] [Full Text] [Related]
13. The characteristics of serum lipid spectrum in PanNENs and its correlation with clinicopathological features and prognosis.
Meng YF; Fan ZY; Yang J; Li YZ; Liu SJ; Gao CH; Gao X; Pang CY; Zhan HX
Front Endocrinol (Lausanne); 2023; 14():1137911. PubMed ID: 37033225
[TBL] [Abstract] [Full Text] [Related]
14. Survival Benefit of Surgical Treatment for Elderly Patients with Intrahepatic Cholangiocarcinoma: A Retrospective Cohort Study in the SEER Database by Propensity Score Matching Analysis.
Chen K; Yu H; Yang J; Bo Z; Jin C; Wu L; Wang Y; Chen G
Curr Oncol; 2023 Feb; 30(3):2642-2652. PubMed ID: 36975414
[TBL] [Abstract] [Full Text] [Related]
15. pancreatic adenosquamous carcinoma: A population level analysis of epidemiological trends and prognosis.
Huang Z; Wang J; Zhang R; He A; Luo S; Wu R; Xiong J; Li M; Jin T; Li E; Wu L; Liao W
Cancer Med; 2023 Apr; 12(8):9926-9936. PubMed ID: 36850060
[TBL] [Abstract] [Full Text] [Related]
16. pancreatic stellate cells exploit Wnt/β-catenin/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth.
Liu H; Zhang H; Liu X; Guo W; Liu Q; Chen L; Pang J; Liu X; Li R; Tong WM; Wu H; Dai M; Liang Z
Cancer Lett; 2023 Feb; 555():216040. PubMed ID: 36565920
[TBL] [Abstract] [Full Text] [Related]
17. Tumor-suppressive miR-29c binds to MAPK1 inhibiting the ERK/MAPK pathway in pancreatic cancer.
Si H; Zhang N; Shi C; Luo Z; Hou S
Clin Transl Oncol; 2023 Mar; 25(3):803-816. PubMed ID: 36510038
[TBL] [Abstract] [Full Text] [Related]
18. Overview and clinical significance of multiple mutations in individual genes in hepatocellular carcinoma.
Imamura T; Okamura Y; Ohshima K; Uesaka K; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Otsuka S; Ohnami S; Nagashima T; Hatakeyama K; Sugino T; Urakami K; Akiyama Y; Yamaguchi K
BMC Cancer; 2022 Oct; 22(1):1046. PubMed ID: 36199046
[TBL] [Abstract] [Full Text] [Related]
19. Exploratory genomic analysis of high-grade neuroendocrine neoplasms across diverse primary sites.
Sun TY; Zhao L; Van Hummelen P; Martin B; Hornbacker K; Lee H; Xia LC; Padda SK; Ji HP; Kunz P
Endocr Relat Cancer; 2022 Dec; 29(12):665-679. PubMed ID: 36165930
[TBL] [Abstract] [Full Text] [Related]
20. Do antihypertensive drugs really have antitumor effects? Baseline differences in hypertensive and non-hypertensive patients with advanced pancreatic cancer.
Iede K; Yamada T; Ueda M; Tsuda Y; Nakashima S; Ohta K; Tanida T; Matsuyama J; Ikenaga M; Tominaga S
Medicine (Baltimore); 2022 Jul; 101(29):e29532. PubMed ID: 35866833
[TBL] [Abstract] [Full Text] [Related]
[Next]
